Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A12 | P48065 | 4/20 | 0.32 |
| ▸ | SLC6A11 | P48066 | 4/20 | 0.32 |
| ▸ | SLC6A13 | Q9NSD5 | 4/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.31 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.31 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10947795 | 0.81 | — | — | |
| SCHEMBL18648931 | 0.81 | — | — | |
| SCHEMBL13107416 | 0.81 | SIGMAR1 (0.31) | SIGMAR1 | |
| SCHEMBL5580145 | 0.79 | FFAR3 (0.31) | SIGMAR1 | |
| SCHEMBL18599678 | 0.76 | ALDH1A1 (0.31) | — | |
| SCHEMBL5966204 | 0.76 | — | — | |
| SCHEMBL10202536 | 0.75 | POLB (0.41) | — | |
| SCHEMBL13619764 | 0.74 | SIGMAR1 (0.44) | SIGMAR1 | |
| SCHEMBL14394124 | 0.74 | CYP2D6 (0.33) | — | |
| SCHEMBL30565914 | 0.74 | ALDH1A1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1376 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12569451-B2 | Bio-inspired tissue-adhesive hydrogel patch and uses thereof | Cellartgen Inc. (KR) | 2026-03-10 | — | — | US | claimed |
| US-20260061091-A1 | MUSSEL-INSPIRED TISSUE ADHESIVES AND METHODS OF USE THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2026-03-05 | — | — | US | claimed |
| US-12383490-B2 | Generic high-capacity protein capture and tunable electrochemical release | NYCTEA TECHNOLOGIES AB (SE) | 2025-08-12 | — | — | US | claimed |
| US-20250221943-A1 | POLYDOPAMINE CO-POLYMER NANOPARTICLES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-07-10 | — | — | US | claimed |
| US-20250204811-A1 | DEVICE, SYSTEMS AND METHOD FOR RECORDING CSF MARKERS | Senso Medical Labs, Ltd. (IL) | 2025-06-26 | — | — | US | claimed |
| EP-4572812-A2 | MUSSEL-INSPIRED TISSUE ADHESIVES AND METHODS OF USE THEREOF | Purdue Research Foundation (US) | 2025-06-25 | — | — | EP | claimed |
| CN-119541903-B | Method for identifying effectiveness of gastrodia elata extract in preventing and treating parkinsonism | 中国农业科学院农产品加工研究所 | 2025-06-13 | — | — | CN | claimed |
| US-20250160380-A1 | NUTRITIONAL COMPOSITION FOR GASTROINTESTINAL ENVIRONMENT TO PROVIDE IMPROVED MICROBIOME AND METABOLIC PROFILE | MEAD JOHNSON NUTRITION COMPANY (US) | 2025-05-22 | — | — | US | claimed |
| CN-119985745-A | Detection method for micromolecular phenolic substances and application thereof | 北京中医药大学 | 2025-05-13 | — | — | CN | claimed |
| US-20250121013-A1 | USE OF BACILLUS AMYLOLIQUEFACIENS FOR PREVENTING AND TREATING PARKINSON'S DISEASE | ARTUGEN THERAPEUTICS LTD. (IE) | 2025-04-17 | — | — | US | claimed |
| WO-2022158784-A1 | DECELLULARIZED TISSUE-DERIVED EXTRACELLULAR MATRIX MODIFIED WITH PHENOL DERIVATIVE AND USE THEREOF | 주식회사 세라트젠 | 2022-07-28 | — | — | WO | claimed |
| US-11357872-B2 | Imaging neurotransmitters in vivo using functionalized carbon nanotubes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-06-14 | — | — | US | claimed |
| CN-114609300-A | Method for evaluating influence of menthol addition on nicotine metabolism of oral nicotine based on animal model | 国家烟草质量监督检验中心 | 2022-06-10 | — | — | CN | claimed |
| EP-3804737-B1 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 4D PHARMA RES LTD (GB) | 2022-05-18 | — | — | EP | claimed |
| WO-2022083754-A1 | LACTIC ACID BACTERIUM FOR TREATMENT OF AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY | LEE WANG TSO (CN) | 2022-04-28 | — | — | WO | claimed |
| US-20220113288-A1 | NEUROTRANSMITTER-BASED BRAIN MAPPING METHOD AND USE OF BRAIN MAP | NEUROVIS INC. (KR) | 2022-04-14 | — | — | US | claimed |
| EP-3981393-A1 | BIOMIMETIC TISSUE-ADHESIVE HYDROGEL PATCH AND USE THEREOF | Cellartgen Inc. (KR) | 2022-04-13 | — | — | EP | claimed |
| WO-2022050695-A1 | EXTRACELLULAR MATRIX-SUPPORTED BIOMIMETIC TISSUE ADHESIVE HYDROGEL PATCH | 주식회사 세라트젠 | 2022-03-10 | — | — | WO | claimed |
| WO-2022050694-A1 | BIOMIMETIC TISSUE-ADHESIVE HYDROGEL PATCH FOR PREVENTING OR TREATING CARTILAGE OR BONE DISEASES | 주식회사 세라트젠 | 2022-03-10 | — | — | WO | claimed |
| WO-2022050682-A1 | EXOSOMES-LOADED BIOMIMETIC TISSUE-ADHESIVE HYDROGEL PATCH | 주식회사 세라트젠 | 2022-03-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250221943-A1 | POLYDOPAMINE CO-POLYMER NANOPARTICLES | PNMT, QDPR, PARN | SLC6A12 352/4885SLC6A11 1437/4885SLC6A13 1219/4885 |
| US-20260061091-A1 | MUSSEL-INSPIRED TISSUE ADHESIVES AND METHODS OF USE THEREOF | CDH1, EPCAM, KEAP1 | SLC6A12 1063/4885SLC6A11 2870/4885SLC6A13 2093/4885 |
| US-12569451-B2 | Bio-inspired tissue-adhesive hydrogel patch and uses thereof | CD44, DBH, ADRB3 | SLC6A12 463/4885SLC6A11 382/4885SLC6A13 418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.